Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1716-1718

  Pfaller, M A ^a,i   Barry, A ^b   Bille, J ^c   Brown, S ^b   Ellis, D ^d   Meis, J F ^e   Rennie, R ^f   Rinaldi, M ^g   Rogers, T ^h   Traczewski, M ^b  

^a UNIVERSITY OF IOWA   (United States)

^b CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e Dept Med Microbiol/Infect Dis ^*  (Netherlands)

^f UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; GLUCOSE; METHYLENE BLUE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOCLAVE; BACTERIUM CULTURE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; FUNGAL STRAIN; FUNGUS CULTURE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

AGAR; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CULTURE MEDIA; EUROPE; GLUCOSE; INTERNATIONAL COOPERATION; LABORATORIES; METHYLENE BLUE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; QUALITY CONTROL; TRIAZOLES;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 16544392676     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1716-1718.2004     Document Type: Article

References (11)

1. Barry, A., J. Bille, S. Brown, D. Ellis, J. Meis, M. Pfaller, R. Rennie, M. Rinaldi, T. Rogers, and M. Traczewski. 2003. Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue. J. Clin. Microbiol. 41:3410-3412.
2. Barry, A. L., M. A. Pfaller, R. P. Rennie, P. C. Fuchs, and S. D. Brown. 2002. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob. Agents Chemother. 46:1781-1784.
3. Espinel-Ingroff, A., K. Boyle, and D. J. Sheehan. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115.
4. Florea, N. R., J. L. Kuti, and R. Quintiliani. 2002. Voriconazole: a novel azole antifungal. Formulary 37:1-10.
5. Ghannoum, M. A., and D. M. Kuhn. 2002. Voriconazole-better chances for patients with invasive mycoses. Eur. J. Med. Res. 7:242-256.
6. Johnson, L. B., and C. A. Kauffman. 2003. Voriconazole: a new triazole antifungal agent. Clin. Infect. Dis. 36:630-637.
7. National Committee for Clinical Laboratory Standards. 2003. Method for antifungal disk diffusion susceptibility testing of yeasts: proposed guideline M44-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Pearson, M. M., P. D. Rogers, J. D. Cleary, and S. W. Chapman. 2003. Voriconazole: a new triazole antifungal agent. Ann. Pharmacother. 37:420-432.
9. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nübling, H. T. Schlamm, I. Lustar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
10. Pfaller, M. A., S. A. Messer, R. J. Hollis, R. N. Jones, and D. J. Diekema. 2002. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 46:1723-1727.
11. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis. 2003. Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol. 41:1440-1446.